[The practice of electroconvulsive therapy at Department of Psychiatry and Psychotherapy, Semmelweis University] [0.03%]
匈牙利塞梅尔维斯大学精神科的电抽搐治疗实践
Levente Hermán,Ilona Bella Császár,Réka Ildikó Zsigmond et al.
Levente Hermán et al.
Electroconvulsive therapy (ECT) is a highly effective biological treatment in psychiatry with a history of nearly one hundred years. In contemporary clinical practice, its primary indications include treatment-resistant affec tive disorders...
Gábor Gazdag,Hunor Girasek,Rozália Takács
Gábor Gazdag
Electroconvulsive therapy (ECT) remains one of the most effective biological treatment methods in psychiatry. The development of convulsive treatment methods was based on a theory of its mechanism of action, namely the presumed biological a...
[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?] [0.03%]
[致幻剂和相关的心理疗法-PAP究竟能帮谁?]
Noémi Papp,Xénia Gonda
Noémi Papp
Psychedelic drugs, historically recognized for their effects on perception, cognition, and emotion, are entering their renaissance, as a growing body of both preclinical and clinical evidence supports their potential for the treatment - mos...
[Anxiolytics and mood stabilizers in modern psychopharmacological practice with an emphasis to specific patient populations] [0.03%]
现代心境稳定剂和抗焦虑药物的临床应用及其在特殊人群中的使用注意事项
János Réthelyi
János Réthelyi
Anxiolytics and mood stabilizers are essential components of modern psychopharmacological practice, with indications spanning multiple diagnostic categories. Although most currently used agents have been available for decades, their clinica...
Erika Szily
Erika Szily
The pharmacological treatment of substance use disorders requires a complex, differentiated approach, in which acute withdrawal treatment, relapse prevention and the treatment of comorbid psychiatric symptoms are imple mented separately, bu...
[Special aspects of the treatment of Alzheimer's disease (Anti-amyloid therapies and management of BPSD)] [0.03%]
阿尔茨海默病治疗的几个特殊问题（抗淀粉样蛋白治疗和BPSD管理）
Zoltán Hidasi,Máté Fullajtár
Zoltán Hidasi
Due to its diverse symptomatology, Alzheimer's disease requires a complex therapeutic approach. Among the disease-modifying pharmacotherapeutic options, significant progress has recently been made in the field of anti-amyloid antibody thera...
[A Practical aspects of managing treatment-resistant depression - with a focus on esketamine] [0.03%]
[治疗抵抗性抑郁的实际管理方面——以艾司氯胺酮为重点]
Csilla Bolyós,Levente Hermán,Péter Döme et al.
Csilla Bolyós et al.
It is relatively common for patients suffering from major depressive disorder to experience no significant improvement in their depressive symptoms despite trying several antidepressants and/or other treatment methods. This phenomenon is re...
[What to do in the case of a failed first antidepressive trial? To switch or to augment?] [0.03%]
抗抑郁药首次单用治疗失败后如何应对？换用新药还是联合用药？
Zoltán Rihmer,Annamária Rihmer
Zoltán Rihmer
Since SSRIs and other new antidepressant agents entered the market, the possibilities to treat depression improved substantially but 50 percent of major depressives do not respond to the first, and 25-35 percent do not respond even to the s...
[Monotherapy vs polypharmacy in psychiatry,practical aspects of monitoring plasma levels of psychotropic drugs] [0.03%]
单药治疗与多药治疗的精神病学实践中的血浆水平监测方面
György Szekeres
György Szekeres
This review examines the changing trends in antipsychotic therapy, with a particular focus on the use of combinations (the administration of multiple antipsychotic drugs simultaneously). In addition to investigating the prevalence of such p...
István Bitter
István Bitter
This publication is an expanded and updated version of three topics selected from a lecture, which was pre sented at a continuing medical education event held in Spring 2025 at the Department of Psychiatry and Psycho therapy at Semmelweis U...